Home LiteratureArticle Details
PMID: 15175443 Published · ppublish English Editorial Comment

Two steps forward in the treatment of colorectal cancer.

The New England journal of medicine ·Vol. 350 ·No. 23 ·2004-06-03 ·Pages 2406-8

Mayer RJ

Abstract

暂无摘要

MeSH Terms
Antibodies, Monoclonal/administration & dosage,economics Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols/therapeutic use Bevacizumab Colorectal Neoplasms/drug therapy,pathology Drug Costs Humans Neoplasm Metastasis/drug therapy Organoplatinum Compounds/administration & dosage Oxaliplatin
Chemicals
Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Organoplatinum Compounds Oxaliplatin Bevacizumab
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Mayer Robert J
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
DOI
10.1056/NEJMe048098
Published
2004-06-03
Pages
2406-8
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 15175435
CommentOn
PMID: 15175436
External Links
PubMed source DOI: 10.1056/NEJMe048098 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2